Both in Pharmaceuticals
Benitec Biopharma vs Enanta Pharmaceuticals
Over the past year BNTC returned −28.7% and ENTA returned +10.1%; their daily moves had a correlation of 0.33.
BNTC −28.7% ENTA +10.1%Growth of $1, one year, split-adjusted
| Metric | BNTC | ENTA |
|---|---|---|
| Price | $10.00 | $13.18 |
| Market cap | $348.8M | $383.9M |
| Today | +2.56% | +4.27% |
| 1 month | −17.8% | −1.1% |
| 6 months | −6.1% | +4.4% |
| Year to date | −25.8% | −16.4% |
| 1 year | −28.5% | −13.1% |
| Revenue growth (YoY) | — | −21.6% |
| Gross margin | — | 100.0% |
| Net margin | — | −135.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 5.9× |
| Net cash | $180.0M | $189.5M |
| Dividend yield | — | — |
| Volatility (60d) | 51.0% | 42.3% |
| Short % of float | 10.4% | 9.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).